肝脏 ›› 2023, Vol. 28 ›› Issue (11): 1351-1355.

• 非酒精性脂肪性肝病 • 上一篇    下一篇

维生素D联合益生菌对肥胖儿童非酒精性脂肪肝的干预效果

刘希, 舒畅   

  1. 710002 陕西 西安市儿童医院感染科三病区
  • 收稿日期:2023-04-20 出版日期:2023-11-30 发布日期:2024-03-03
  • 通讯作者: 舒畅

Combined effects of vitamin D and probiotics on nonalcoholic fatty liver disease in obese pediatric patients

LIU Xi, SHU Chang   

  1. Third ward of Infection Department, Xi’an Children’s Hospital, Shaanxi 710002, China
  • Received:2023-04-20 Online:2023-11-30 Published:2024-03-03
  • Contact: SHU Chang

摘要: 目的 探讨维生素D联合益生菌对肥胖儿童非酒精性脂肪肝(NAFLD)的治疗效果。方法 选取西安市儿童医院收治的105例NAFLD肥胖儿童作为研究对象,使用随机数字表法分为3组(各35例),对照组患儿给予营养及生活方式干预,A组在对照组基础上加用益生菌,B组在对照组基础上加用维生素D和益生菌。对比3组患儿干预前后的体重指数(BMI)、肝功能指标、糖脂代谢指标、胰岛素抵抗指数(HOMA-IR)及炎性因子水平等变化。结果 3组干预后的BMI、AST及ALT水平均较干预前明显降低(P<0.05),A组和B组的BMI值接近(P>0.05),但均低于对照组(P<0.05);AST和ALT水平表现为B组<A组<对照组,且两两对比差异均有统计学意义(P<0.05)。与干预前相比,3组患儿干预后的HOMA-IR、TC、TG水平均明显降低(P<0.05),组间比较显示HOMA-IR、TC、TG水平表现为B组<A组<对照组,且两两比较差异均有统计学意义(P<0.05)。与干预前相比,B组干预后的25(OH)D3水平显著升高,TNF-α、IL-6水平显著降低(P<0.05)。A组和对照组干预前后的25(OH)D3、TNF-α及IL-6水平均无明显变化(P>0.05)。A组和B组干预后的肠道菌群失调率分别为45.71%、37.14%,均较干预前的85.71%和80.00%明显降低(P<0.05),对照组干预前后肠道菌群失调率(74.29%比71.43%)无明显变化(P>0.05)。A组与B组干预后的肠道菌群失调率(45.71%比37.14%)接近(P>0.05)。3组的治疗总有效率比较,B组(94.29%)>A组(80.00%)>对照组(60.00%),且组间两两比较差异有统计学意义(P<0.05)。结论 对于NAFLD肥胖儿童在生活方式干预基础上加用益生菌和维生素D,能够有效改善患儿的糖脂代谢,减轻胰岛素抵抗,降低炎性因子水平,改善肝功能。

关键词: 非酒精性脂肪肝, 肥胖, 儿童, 维生素D, 益生菌, 胰岛素抵抗

Abstract: Objective To explore the combined therapeutic effects of vitamin D and probiotics on nonalcoholic fatty liver disease (NAFLD) in pediatric obesity.Methods 105 obese children diagnosed with NAFLD were enrolled from our hospital and were randomized into three groups (35 cases each) using a stratified random number table. The control group underwent nutritional and lifestyle interventions. In addition to the control goup`s interventions, Group A was administered probiotics, while Group B was given both vitamin D and probiotics. The changes of body mass index (BMI), liver function metrics, glucose and lipid metabolismmarkers, insulin resistance index (HOMA-IR), and inflammatory cytokines levels amont the three groups before and after the intervention were compared.Results After the intervention, there was a notable reduction in the levels of BMI, AST, and ALT across all three groups compared to their pre-intervention levels (P<0.05). On comparing between groups, BMI measurements in Group A and B were statistically comparable (P>0.05), yet both displayed significantly reductions when contrasted with the control group (P<0.05); The levels of AST and ALT in Group B were reduced compared to both Group A and the control group (P<0.05). Post-intevention levels of HOMA-IR, TC, and TG in the three groups also significantly decreased compared to their initial values(P<0.05). An intergroup analysis revealved that the levels of HOMA-IR, TC, and TG in Group B were substantially lower than in Group A, with the difference being statistically significant (P<0.05). In group B, post-intervetion 25 (OH) D3 levels significantly surged, while TNF- α and IL-6 levels saw a considerable decline(P<0.05). Conversly, in both Group A and the control group, no significant fluctuations were obderved in the levels of 25 (OH) D3, TNF- α and IL-6 before and after the intervention(P>0.05). After the intervention, the rates of intestinal microbiota dysbiosis in Group A and B reduced to 45.71% and 37.14% respectively, showing a significant decline from their pre-intervention values of 85.71% and 80.00% (P<0.05). In conreast, the control group′s dysbiosis rate showed no significant alteration, remaining relatively stable at 74.29% pre-intervention and 71.43% post-intervention(P>0.05). The post-intervention imbalance rates of intestinal microbiota were conparable between Group A and Group B(45.71% vs 37.14%, P>0.05). When evaluating the overall treatment efficacy, Group B exhibited the highest rate at 94.29%, followed by Group A at 80.00%, and the Control Group lagging behing at 60.00%. The differences in effective rates between the groups were statistically significant(P<0.05).Conclusion Incorporating probiotics and vitamin D into lifestyle interventions for obese children with NAFLD has been shown to effectively improve their glucose and lipid metabolism, diminish insulin resistance, lower inflammatory cytokine levels, and ameliorate liver function.

Key words: Non-alcoholic fatty liver disease, Obesity, Children, Vitamin D, probiotics, insulin resistance